2PU

PULMATRIX INC. DL-0001

Healthcare · EUR · F

2PU

Price

€0.941

+0.53%

Cap

€4.74M

Earnings

30d Trend

-5.0%

2PU
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

117% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality29
Momentum21
Technical45
Fundamentals90

Raw weighted: 28×Macro 0.99 (1%)=28

RISK

85/100
90d Volatility
117.1%High
ATR %
5.8%High daily moves
Max Drawdown (1Y)
-86.9%Volatile

QUALITY

29/100
Piotroski F-Score
4/9Average
Accruals
6.5%Accrual heavy

MOMENTUM

21/100
12-1M Momentum
-94.5%Strong downtrend
6-1M Momentum
-80.3%Negative
1M Return
+11.3%Strong recent gains
Relative Strength
+2.4% vs sectorIn-line

TECHNICAL

45/100
RSI (14)
54.0Neutral
Price vs SMA200
-57.0%Bearish trend
MACD
+0.03Bullish momentum
Bollinger Band
94%Near upper band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.304Mixed

FUNDAMENTALS

90/100
P/S
0.6Cheap

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months61
3-12 months22
1-5+ years46

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate PULMATRIX INC. DL-0001 at 28/100 — a WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 90/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+11.3%

3 MONTHS

-53.8%

12 MONTHS

-83.2%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Fundamentals (90) and Technical (45) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 117%. I classify this as a speculative position — elevated volatility at 117% and smaller market cap define the opportunity.

speculativeScore: 28/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.